Turning complex clinical data into investment clarity.

Khora analyzes clinical trials, regulatory data, and scientific evidence to evaluate the credibility of biotech innovation, helping investors assess risk and identify opportunities with confidence.

90%

4-24

$2.6B

of drug candidates fail before approval

weeks of diligence based on complexity

of biotech / life sciences company

average cost per approved drug

Clinical Trial Analysis

Khora automatically assesses methodology, statistical validity, and endpoint design across thousands of clinical trials — surfacing the signals that matter most.

"At GlycoX, we're excited about Khora's potential to provide independent, standardized validation of what truly constitutes strong, meaningful data.  Beyond helping VCs allocate capital more effectively, this kind of platform can accelerate the path from discovery to real solutions that improve patients' lives."

Co-founder and CEO, GlycoX

Matias Gonzalez

Data Sources

Analysis Speed

Scoring Methodology

Continuous Monitoring

Khora

Integrates clinical trial registries, FDA filings, PubMed, and proprietary datasets into a unified analysis.

Delivers comprehensive credibility assessments in minutes, enabling real-time due diligence.

Proprietary evidence-based scoring combining statistical validity, trial design quality, and regulatory alignment.

Automated alerts on trial updates, regulatory changes, and new evidence that impacts credibility scores.

Other Solutions

Relies on manually curated reports and limited public data, requiring significant analyst time.

Weeks of manual review by specialized analysts before investment recommendations are finalized.

Subjective expert opinions with inconsistent frameworks across different analysts and firms.

Periodic manual updates that often miss critical developments between review cycles.

Get early access to our beta, and Khora product updates

Evidence-based credibility scoring

Our proprietary algorithm evaluates trial methodology, statistical validity, endpoint rigor, and regulatory alignment to generate a comprehensive credibility score for any biotech claim.

Real-time regulatory monitoring

Track FDA submissions, EMA filings, and global regulatory developments as they happen.

Get instant alerts when new data impacts your portfolio companies.

Portfolio risk assessment

Continuously monitor the clinical evidence landscape for all companies in your portfolio. Identify emerging risks before they impact valuations.

Clinical Credibility Score

Track, analyze, and improve your investment decisions—focus on credibility, measure risk with real-time data, and uncover opportunities for better returns.

87%

Trial Design Score

Based on 24 parameters

↑ 12% from Phase I

92%

Statistical Validity

Across 3 endpoints

↑ 8% vs. industry avg

Khora Venture Capital

Quantifying scientific risk to drive smarter biotech investment decisions.

Khora Markets

Translating clinical evidence into real-time signals for biotech markets.

Khora Portfolio

A unified intelligence layer for tracking and benchmarking biotech assets.

Khora Reports

Institutional-grade analysis turning complex science into actionable insight.

Khora Clinical

Standardizing trial quality to accelerate better clinical outcomes.

Khora Founder

Equipping biotech founders with the data to build and fund credible science.

Khora Regulatory

De-risking regulatory pathways through structured evidence intelligence.